Trials / Unknown
UnknownNCT03874481
The Effect of Sleep Quality on Coronary Artery Disease and In Stent Restenosis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 958 (estimated)
- Sponsor
- China National Center for Cardiovascular Diseases · Other Government
- Sex
- All
- Age
- 30 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
This is a cross-sectional and follow-up study. We analysis the relationship of sleep quality on coronary artery disease(CAD) and in stent restenosis(ISR). Further, we explore the mechanism of relationship between the sleep quality and CAD/ ISR by examining the biomarkers in the pathway of sleep-CAD/ISR.
Detailed description
Background: Coronary artery disease (CAD) is the leading cause of mortality in the world. The important treatment of CAD is Percutaneous coronary intervention(PCI). However, in-stent-restenosis(ISR) is the major issue in the PCI. The factors of ISR include gender, age, diabetes, lipid ,obesity and so on.Recently, studies showed that sleep duration and sleep quality have effect on all of factors and have relationship with coronary artery calcification. We like to explore the relationship between sleep quality and CAD/ISR. Aims:This is a cross-sectional and follow-up study. We analysis the relationship of sleep quality on coronary artery disease(CAD) and in stent restenosis(ISR). Further, we explore the mechanism of relationship between the sleep quality and CAD/ ISR by examining the biomarkers in the pathway of sleep-CAD/ISR. Methods: We include patients who were diagnosed as CAD by coronary arteriography. Sleep duration and quality were evaluated from sleep questionnaire. During the 6 months and 9-12months, we follow up the patients who got PCI and get information of Major Adverse Cardiovascular Events (MACE) from follow-up questionnaire. On 9-12 months after PCI, coronary arteriography were produced in PCI patients. Biomarkers were tested during the follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation | follow up regularly for MACE |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2020-10-31
- Completion
- 2020-10-31
- First posted
- 2019-03-14
- Last updated
- 2019-03-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03874481. Inclusion in this directory is not an endorsement.